Primary prophylaxis using G-CSF was clearly demonstrated to prevent the development of neutropenia and to reduce the rate of infection and infection-related mortality in adult cancer patients receiving chemotherapy [34, 35]. The gene discussed is CSF3; the disease is cancer.